To our surprise, when we overexpressed HAS2 and HYAL1 in the luminal BC cell line MCF7, neither increased tumor cell adhesion, nor migration through the brain endothelium, nor any morphological alteration was observed. The gene discussed is HAS2; the disease is breast cancer.